浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2013年
10期
911-913
,共3页
叶瑞海%张鸣华%慈晓%上官宗校%林海%赵仁国%许建华
葉瑞海%張鳴華%慈曉%上官宗校%林海%趙仁國%許建華
협서해%장명화%자효%상관종교%림해%조인국%허건화
慢性阻塞性肺疾病%组蛋白去乙酰化酶类%降钙素原%C反应蛋白
慢性阻塞性肺疾病%組蛋白去乙酰化酶類%降鈣素原%C反應蛋白
만성조새성폐질병%조단백거을선화매류%강개소원%C반응단백
Chronic obstructive pulmonary disease%Histone deacetylase%Procalcitonin%C-reactive protein
目的探讨慢性阻塞性肺疾病(COPD)急性加重期患者外周血组蛋白去乙酰化酶2(histone deacetylase 2, HDAC2)的表达及其与C反应蛋白(CRP)、降钙原素(PCT)的关系.方法选择67例COPD急性加重期患者,根据病情分为轻、中、重度3组,均行肺功能检查.选择同期体检中心20例健康体检者为对照组.ELISA双抗体夹心法测定HDAC2表达水平,免疫比浊法测定炎症蛋白CRP、PCT浓度.结果随着病情的加重,外周血炎症蛋白CRP、PCT浓度显著升高,而HDAC2浓度呈逐渐下降趋势,各组间的差异均有统计学意义(均P<0.01).HDAC2表达水平和炎症蛋白PCT浓度呈负相关(P<0.05).结论 HDAC2可能是COPD急性加重期患者炎症反应的负调控因子.
目的探討慢性阻塞性肺疾病(COPD)急性加重期患者外週血組蛋白去乙酰化酶2(histone deacetylase 2, HDAC2)的錶達及其與C反應蛋白(CRP)、降鈣原素(PCT)的關繫.方法選擇67例COPD急性加重期患者,根據病情分為輕、中、重度3組,均行肺功能檢查.選擇同期體檢中心20例健康體檢者為對照組.ELISA雙抗體夾心法測定HDAC2錶達水平,免疫比濁法測定炎癥蛋白CRP、PCT濃度.結果隨著病情的加重,外週血炎癥蛋白CRP、PCT濃度顯著升高,而HDAC2濃度呈逐漸下降趨勢,各組間的差異均有統計學意義(均P<0.01).HDAC2錶達水平和炎癥蛋白PCT濃度呈負相關(P<0.05).結論 HDAC2可能是COPD急性加重期患者炎癥反應的負調控因子.
목적탐토만성조새성폐질병(COPD)급성가중기환자외주혈조단백거을선화매2(histone deacetylase 2, HDAC2)적표체급기여C반응단백(CRP)、강개원소(PCT)적관계.방법선택67례COPD급성가중기환자,근거병정분위경、중、중도3조,균행폐공능검사.선택동기체검중심20례건강체검자위대조조.ELISA쌍항체협심법측정HDAC2표체수평,면역비탁법측정염증단백CRP、PCT농도.결과수착병정적가중,외주혈염증단백CRP、PCT농도현저승고,이HDAC2농도정축점하강추세,각조간적차이균유통계학의의(균P<0.01).HDAC2표체수평화염증단백PCT농도정부상관(P<0.05).결론 HDAC2가능시COPD급성가중기환자염증반응적부조공인자.
Objective To investigate histone deacetylase 2 (HDAC2) levels in peripheral blood of patients with acute ex-acerbation of chronic obstructive pulmonary disease (COPD). Methods Sixty-seven patients with COPD in acute exacerbation were enrol ed in the study. Lung function tests were performed to evaluate disease severity and patients were classified as mild, moderate and severe groups. Twenty healthy subjects served as controls. The HDAC2 levels were measured by ELISA. The in-flammatory proteins C-reactive protein (CRP) and procalcitonin (PCT) were measured by immunoturbidimetric assay. Results The CRP and PCT levels were increased in COPD patients as compared to healthy controls. The HDAC2 levels in mild, moderate and severe groups were 6.93±1.25, 6.42±1.46 and 3.79±1.12, respectively (P<0.01). HDAC2 level was negatively correlated with inflammatory protein PCT (P<0.05). Conclusion HDAC2 levels are decreased in peripheral blood of COPD patients and correlated with the severity of disease, indicating that it may be a negative regulator of inflammatory response in patients with COPD.